BackChembio Diagnostics Overview

Chembio Diagnostics Long Term Debt

Track Chembio Diagnostics's long-term debt ($5.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$5.51M
76.74% YoYΔ $-18.19M vs prior year quarter

Peer average

Loading

Chembio Diagnostics Long Term Debt History

Loading

Chembio Diagnostics vs. peers: Long Term Debt Comparison

Loading

Chembio Diagnostics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Chembio Diagnostics (CEMI) FAQ

As of the most recent data (December 2022), CEMI shows a long-term debt of $5.5M. That compares with $24M in the prior-year period — down 76.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CEMI's long-term debt is now $5.5M (was $24M) — a 76.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Chembio Diagnostics is outperforming or lagging.

Tracking CEMI's long-term debt over time shows whether Chembio Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $5.5M That compares with $24M in the prior-year period — down 76.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Chembio Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $5.5M) with ownership activity and broader fundamentals.

Chembio Diagnostics's long-term debt is $5.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.